The Cholinergic Drug Galantamine Alleviates Oxidative Stress Alongside Anti-inflammatory and Cardio-Metabolic Effects in Subjects With the Metabolic Syndrome in a Randomized Trial
Background: The metabolic syndrome (MetS) is an obesity-associated disorder of pandemic proportions and limited treatment options. Oxidative stress, low-grade inflammation and altered neural autonomic regulation, are important components and drivers of pathogenesis. Galantamine, an acetylcholinester...
Main Authors: | Carine Teles Sangaleti, Keyla Yukari Katayama, Kátia De Angelis, Tércio Lemos de Moraes, Amanda Aparecida Araújo, Heno F. Lopes, Cleber Camacho, Luiz Aparecido Bortolotto, Lisete Compagno Michelini, Maria Cláudia Irigoyen, Peder S. Olofsson, Douglas P. Barnaby, Kevin J. Tracey, Valentin A. Pavlov, Fernanda Marciano Consolim Colombo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.613979/full |
Similar Items
-
Efeitos da galantamina sobre biomarcadores inflamatórios e adipocinas em pacientes com síndrome metabólica
by: Miyahara, Carine Teles Sangaleti
Published: (2017) -
Efeitos da galantamina sobre biomarcadores inflamatórios e adipocinas em pacientes com síndrome metabólica
by: Carine Teles Sangaleti Miyahara
Published: (2017) -
Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
by: Ben Seltzer
Published: (2009-12-01) -
Preparation and evaluation of novel galantamine hydrobromide sustained-release capsule
by: Shuoye Yang
Published: (2016-03-01) -
A Galantamine–Curcumin Hybrid Decreases the Cytotoxicity of Amyloid-Beta Peptide on SH-SY5Y Cells
by: Kirilka Mladenova, et al.
Published: (2021-07-01)